Found: 1
Select item for more details and to access through your institution.
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02034-7
- By:
- Publication type:
- Article